As blockbuster GLP-1 injectables like Mounjaro, Wegovy and Ozempic gain traction in India, doctors stress that careful ...

Reducing injection burden has long been a priority in diabetes care. Now, a weekly, fixed-dose combination of basal insulin and a GLP-1 receptor agonist is one step closer to approval in Europe.

These meds are sometimes prescribed off-label for people with overweight or obesity. Most of these diabetes drugs promote weight loss by suppressing appetite and making you feel fuller. You might have ...

Stopping weight-loss injections like Mounjaro or Wegovy often leads to weight regain and loss of heart health benefits, ...